The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)
Authors:
Open Access
- 10 October 2012
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 56 (1) , 112-120
Abstract
Aims/hypothesis Insulin clearance may decline as an early mechanism compensating for deteriorating insulin sensitivity. However, no previous studies have investigated the association between subclinical inflammation or impaired fibrinolysis and insulin clearance. We examined the association between plasminogen activator inhibitor (PAI)-1, C-reactive protein (CRP), TNF-α, leptin and fibrinogen and the progression of metabolic clearance rate of insulin (MCRI) over time. Methods We studied 784 non-diabetic white, Hispanic and African-American individuals in the Insulin Resistance Atherosclerosis Study (IRAS). Insulin sensitivity, acute insulin response and MCRI were determined from frequently sampled intravenous glucose tolerance tests at baseline and at 5-year follow-up. Inflammatory and fibrinolytic proteins were measured in fasting plasma at baseline. Results MCRI had declined significantly by 29% at the 5-year follow-up. We observed a significant association between higher plasma PAI-1 levels and the decline in MCRI in multivariable-adjusted regression models (β = −0.045 [95% CI −0.081, −0.0091]). Higher plasma CRP and leptin levels were associated with a decline in MCRI in unadjusted models, but these associations were non-significant after adjusting for BMI and waist circumference (β = −0.016 [95% CI −0.041, 0.0083] for CRP; β = −0.044 [95% CI −0.10, 0.011] for leptin). A higher plasma TNF-α concentration was associated with a decline in MCRI in unadjusted (β = −0.071 [95% CI −0.14, −0.00087]) but not in multivariable-adjusted (β = −0.056 [95% CI −0.13, 0.017]) models. Plasma fibrinogen level was not associated with the change in MCRI. Conclusions/interpretation We identified that higher plasma PAI-1 (but not CRP, TNF-α, leptin or fibrinogen) levels independently predicted the progressive decline of insulin clearance in the multiethnic cohort of the IRAS.Keywords
This publication has 53 references indexed in Scilit:
- Circulating Levels of TNF-α Are Associated with Impaired Glucose Tolerance, Increased Insulin Resistance, and Ethnicity: The Insulin Resistance Atherosclerosis StudyThe Journal of Clinical Endocrinology & Metabolism, 2012
- Differential White Blood Cell Count and Type 2 Diabetes: Systematic Review and Meta-Analysis of Cross-Sectional and Prospective StudiesPLOS ONE, 2010
- First-Trimester Prediction of Gestational Diabetes Mellitus: Examining the Potential of Combining Maternal Characteristics and Laboratory MeasuresDiabetes, 2010
- Inflammation and the Incidence of Type 2 DiabetesDiabetes Care, 2010
- Insulin Resistance, β-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic PopulationDiabetes Care, 2009
- Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points UpstreamPLOS Medicine, 2008
- Relation of Low Glomerular Filtration Rate to Metabolic Disorders in Individuals without Diabetes and with NormoalbuminuriaClinical Journal of the American Society of Nephrology, 2008
- TNF‐α and adipocyte biologyFEBS Letters, 2007
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993